ITEM VIEW

Intra- and inter-clade cross-reactivity by HIV-1 gag specific T-cells reveals exclusive and commonly targeted regions : implications for current vaccine trials

dc.contributor.authorZembe, Lyciasen_ZA
dc.contributor.authorBurgers, Wendy A.en_ZA
dc.contributor.authorJaspan, Heather B.en_ZA
dc.contributor.authorBekker, Linda-Gailen_ZA
dc.contributor.authorBredell, Helbaen_ZA
dc.contributor.authorStevens, Gwynnethen_ZA
dc.contributor.authorGilmour, Jillen_ZA
dc.contributor.authorCox, Josephine H.en_ZA
dc.contributor.authorFast, Patriciaen_ZA
dc.contributor.authorHayes, Peteren_ZA
dc.contributor.authorVardas, Eftyhiaen_ZA
dc.contributor.authorWilliamson, Carolynen_ZA
dc.contributor.authorGray, Clive M.en_ZA
dc.date.accessioned2013-02-26T07:34:05Z
dc.date.available2013-02-26T07:34:05Z
dc.date.issued2011-10-12
dc.identifier.citationZembe, L., et al. 2011. Intra- and inter-clade cross-reactivity by HIV-1 gag specific T-cells reveals exclusive and commonly targeted regions : implications for current vaccine trials. PLoS ONE, 6(10): 1-12, doi: 10.1371/journal.pone.0026096
dc.identifier.issn1932-6203 (online)
dc.identifier.issn1932-6203 (print)
dc.identifier.otherdoi: 10.1371/journal.pone.0026096
dc.identifier.urihttp://hdl.handle.net/10019.1/79610
dc.descriptionCITATION: Zembe, L., et al. 2011. Intra- and inter-clade cross-reactivity by HIV-1 gag specific T-cells reveals exclusive and commonly targeted regions : implications for current vaccine trials. PLoS ONE, 6(10): 1-12, doi: 10.1371/journal.pone.0026096.
dc.descriptionThe original publication is available at http://journals.plos.org/plosone
dc.description.abstractENGLISH ABSTRACT: The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. To facilitate immunogen design, it is important to characterize clusters of commonly targeted T-cell epitopes across different HIV clades. To address this, we examined 39 HIV-1 clade C infected individuals for IFN-c Gag-specific T-cell responses using five sets of overlapping peptides, two sets matching clade C vaccine candidates derived from strains from South Africa and China, and three peptide sets corresponding to consensus clades A, B, and D sequences. The magnitude and breadth of T-cell responses against the two clade C peptide sets did not differ, however clade C peptides were preferentially recognized compared to the other peptide sets. A total of 84 peptides were recognized, of which 19 were exclusively from clade C, 8 exclusively from clade B, one peptide each from A and D and 17 were commonly recognized by clade A, B, C and D. The entropy of the exclusively recognized peptides was significantly higher than that of commonly recognized peptides (p = 0.0128) and the median peptide processing scores were significantly higher for the peptide variants recognized versus those not recognized (p = 0.0001). Consistent with these results, the predicted Major Histocompatibility Complex Class I IC50 values were significantly lower for the recognized peptide variants compared to those not recognized in the ELISPOT assay (p,0.0001), suggesting that peptide variation between clades, resulting in lack of cross-clade recognition, has been shaped by host immune selection pressure. Overall, our study shows that clade C infected individuals recognize clade C peptides with greater frequency and higher magnitude than other clades, and that a selection of highly conserved epitope regions within Gag are commonly recognized and give rise to cross-clade reactivities.en_ZA
dc.description.urihttp://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026096
dc.format.extent12 pagesen_ZA
dc.language.isoen_ZAen_ZA
dc.publisherPublic Library of Scienceen_ZA
dc.subjectVaccines -- Testingen_ZA
dc.subjectImmunogen designen_ZA
dc.subjectT-cell -- Epitopesen_ZA
dc.subjectHIV (Viruses)en_ZA
dc.subjectHIV-1 clade Cen_ZA
dc.subjectIFN-c Gag-specific T-cellen_ZA
dc.titleIntra- and inter-clade cross-reactivity by HIV-1 gag specific T-cells reveals exclusive and commonly targeted regions : implications for current vaccine trialsen_ZA
dc.typeArticleen_ZA
dc.description.versionPublisher's versionen_ZA
dc.rights.holderAuthors retain copyrighten_ZA


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW